WESTERN ALLIANCE BANCORP (WAL)

US9576381092 - Common Stock

84.62  +1.76 (+2.12%)

After market: 86 +1.38 (+1.63%)

Fundamental Rating

3

WAL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 406 industry peers in the Banks industry. WAL may be in some trouble as it scores bad on both profitability and health. WAL is not valued too expensively and it also shows a decent growth rate.



3

1. Profitability

1.1 Basic Checks

In the past year WAL was profitable.
In the past year WAL has reported a negative cash flow from operations.
WAL had positive earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: WAL reported negative operating cash flow in multiple years.

1.2 Ratios

The Return On Assets of WAL (0.88%) is better than 60.89% of its industry peers.
With a decent Return On Equity value of 10.57%, WAL is doing good in the industry, outperforming 77.23% of the companies in the same industry.
Industry RankSector Rank
ROA 0.88%
ROE 10.57%
ROIC N/A
ROA(3y)1.38%
ROA(5y)1.48%
ROE(3y)16.41%
ROE(5y)16.12%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin of WAL (23.48%) is comparable to the rest of the industry.
WAL's Profit Margin has declined in the last couple of years.
WAL does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 23.48%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.85%
PM growth 5Y-9.83%
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

WAL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for WAL has been increased compared to 1 year ago.
Compared to 5 years ago, WAL has more shares outstanding
WAL has a better debt/assets ratio than last year.

2.2 Solvency

A Debt/Equity ratio of 0.36 indicates that WAL is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.36, WAL is doing worse than 70.05% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC12.53%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

6

3. Growth

3.1 Past

The earnings per share for WAL have decreased strongly by -18.59% in the last year.
Measured over the past years, WAL shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.17% on average per year.
The Revenue has grown by 13.92% in the past year. This is quite good.
The Revenue has been growing by 22.26% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-18.59%
EPS 3Y16.62%
EPS 5Y14.17%
EPS Q2Q%-2.17%
Revenue 1Y (TTM)13.92%
Revenue growth 3Y28.39%
Revenue growth 5Y22.26%
Sales Q2Q%14.93%

3.2 Future

The Earnings Per Share is expected to grow by 10.61% on average over the next years. This is quite good.
Based on estimates for the next years, WAL will show a quite strong growth in Revenue. The Revenue will grow by 10.35% on average per year.
EPS Next Y-10.21%
EPS Next 2Y6.73%
EPS Next 3Y10.61%
EPS Next 5YN/A
Revenue Next Year13.19%
Revenue Next 2Y10.82%
Revenue Next 3Y10.35%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.85, which indicates a very decent valuation of WAL.
Based on the Price/Earnings ratio, WAL is valued a bit cheaper than the industry average as 66.83% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.73. WAL is valued rather cheaply when compared to this.
WAL is valuated reasonably with a Price/Forward Earnings ratio of 9.27.
WAL's Price/Forward Earnings ratio is rather cheap when compared to the industry. WAL is cheaper than 82.43% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.83, WAL is valued rather cheaply.
Industry RankSector Rank
PE 11.85
Fwd PE 9.27

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.84
EPS Next 2Y6.73%
EPS Next 3Y10.61%

4

5. Dividend

5.1 Amount

WAL has a Yearly Dividend Yield of 1.83%. Purely for dividend investing, there may be better candidates out there.
WAL's Dividend Yield is slightly below the industry average, which is at 3.02.
Compared to an average S&P500 Dividend Yield of 2.24, WAL has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.83%

5.2 History

WAL has been paying a dividend for over 5 years, so it has already some track record.
As WAL did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)N/A
Div Incr Years5
Div Non Decr Years5

5.3 Sustainability

24.86% of the earnings are spent on dividend by WAL. This is a low number and sustainable payout ratio.
DP24.86%
EPS Next 2Y6.73%
EPS Next 3Y10.61%

WESTERN ALLIANCE BANCORP

NYSE:WAL (12/20/2024, 8:04:00 PM)

After market: 86 +1.38 (+1.63%)

84.62

+1.76 (+2.12%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-17 2024-10-17/amc
Earnings (Next)01-23 2025-01-23/amc
Inst Owners83.33%
Inst Owner Change6.7%
Ins Owners2.64%
Ins Owner Change-1.68%
Market Cap9.31B
Analysts83
Price Target101.46 (19.9%)
Short Float %6.05%
Short Ratio5.82
Dividend
Industry RankSector Rank
Dividend Yield 1.83%
Dividend Growth(5Y)N/A
DP24.86%
Div Incr Years5
Div Non Decr Years5
Ex-Date11-15 2024-11-15 (0.38)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.1%
Min EPS beat(2)-5.47%
Max EPS beat(2)-0.72%
EPS beat(4)2
Avg EPS beat(4)-0.72%
Min EPS beat(4)-5.47%
Max EPS beat(4)2.5%
EPS beat(8)3
Avg EPS beat(8)0.24%
EPS beat(12)5
Avg EPS beat(12)0.22%
EPS beat(16)9
Avg EPS beat(16)5.47%
Revenue beat(2)2
Avg Revenue beat(2)2.22%
Min Revenue beat(2)0.84%
Max Revenue beat(2)3.6%
Revenue beat(4)3
Avg Revenue beat(4)0.82%
Min Revenue beat(4)-3.39%
Max Revenue beat(4)3.6%
Revenue beat(8)5
Avg Revenue beat(8)-1.55%
Revenue beat(12)7
Avg Revenue beat(12)-1.08%
Revenue beat(16)10
Avg Revenue beat(16)-0.39%
PT rev (1m)4.42%
PT rev (3m)14.23%
EPS NQ rev (1m)0.06%
EPS NQ rev (3m)-8.78%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.54%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)3.18%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE 11.85
Fwd PE 9.27
P/S 3.1
P/FCF N/A
P/OCF N/A
P/B 1.39
P/tB 1.86
EV/EBITDA N/A
EPS(TTM)7.14
EY8.44%
EPS(NY)9.13
Fwd EY10.78%
FCF(TTM)-16.93
FCFYN/A
OCF(TTM)-16.16
OCFYN/A
SpS27.31
BVpS60.66
TBVpS45.47
PEG (NY)N/A
PEG (5Y)0.84
Profitability
Industry RankSector Rank
ROA 0.88%
ROE 10.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 23.48%
GM N/A
FCFM N/A
ROA(3y)1.38%
ROA(5y)1.48%
ROE(3y)16.41%
ROE(5y)16.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.85%
PM growth 5Y-9.83%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 100.84%
Cap/Sales 2.81%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC12.53%
ROIC/WACCN/A
Cap/Depr(3y)218.82%
Cap/Depr(5y)192.64%
Cap/Sales(3y)4.49%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.59%
EPS 3Y16.62%
EPS 5Y14.17%
EPS Q2Q%-2.17%
EPS Next Y-10.21%
EPS Next 2Y6.73%
EPS Next 3Y10.61%
EPS Next 5YN/A
Revenue 1Y (TTM)13.92%
Revenue growth 3Y28.39%
Revenue growth 5Y22.26%
Sales Q2Q%14.93%
Revenue Next Year13.19%
Revenue Next 2Y10.82%
Revenue Next 3Y10.35%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-195.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-186.12%
OCF growth 3YN/A
OCF growth 5YN/A